Novo Nordisk to begin 2024 share buybacks
Novo Nordisk will on Tuesday begin the execution of its planned share buyback programme for 2024, the Danish maker of obesity drug Wegovy and diabetes treatment Ozempic said in a statement.
Symbol | Last Price | Change | % Change |
---|---|---|---|